Westwood Holdings Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
SCM
RCMC
BCM
RIM
Westwood Holdings Group's IRMD Position: Q2 2023 in Review
Westwood Holdings Group sold out of iRadimed (IRMD) in Q2 2023, closing a stake of 11,840 shares — an estimated $466K sold.
Westwood Holdings Group first reported a position in IRMD in Q1 2023 and held it in 1 quarter. The position peaked at $466K in Q1 2023. 112 funds tracked by Wall St. Rank hold IRMD as of Q2 2023.
- Westwood Holdings Group reported no remaining iRadimed position as of Q2 2023 after selling out during the quarter.
- Westwood Holdings Group sold 11,840 iRadimed shares in Q2 2023, an estimated $466K.
- Westwood Holdings Group first reported a position in iRadimed in Q1 2023 and held it in 1 quarter.
- Westwood Holdings Group's iRadimed position peaked at $466K in Q1 2023.
- 112 funds tracked by Wall St. Rank held iRadimed as of Q2 2023.
Based on Westwood Holdings Group's 13F filing for Q2 2023, filed 11 Aug 2023.